Combined RNA-expression and 2D-PAGE-screening identifies comprehensive interaction networks affected after bortezomib or enzastaurin exposure of mantle cell lymphoma

Talanta

Volumn 80, Issue 4, 2010, Pages 1539-1544

  Weinkauf, Marc ^a   Hutter, Grit ^a   Zimmermann, Yvonne ^a   Hartmann, Elena ^b   Rosenwald, Andreas ^b   Dreyling, Martin ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Bortezomib; Enzastaurin; Mantle cell lymphoma; Network anaylsis; Proteomics; RNA expression array

Indexed keywords

CELL DEATH; DISEASE CONTROL; MOLECULAR BIOLOGY; ONCOLOGY; PROTEINS; REFRACTORY MATERIALS; RNA; SURVEYS;

BORTEZOMIB; ENZASTAURIN; HIGH THROUGHPUT SCREENING METHODS; INTERACTION NETWORKS; MANTLE CELLS; PROTEASOME INHIBITORS; PROTEOMICS; SCREENING TECHNIQUES;

DIAGNOSIS;

EID: 71749085030     PISSN: 00399140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.talanta.2009.06.023     Document Type: Article

References (15)

1. Dreyling M., Weigert O., and Hiddemann W. Ann. Oncol. 19 Suppl. 4 (2008) iv41-iv44
2. Goy A., Bernstein S.H., Kahl B.S., Djulbegovic B., Robertson M.J., de Vos S., Epner E., Krishnan A., Leonard J.P., Lonial S., Nasta S., O'Connor O.A., Shi H., Boral A.L., and Fisher R.I. Ann. Oncol. 20 (2009) 520-525
3. Morschhauser F., Seymour J.F., Kluin-Nelemans H.C., Grigg A., Wolf M., Pfreundschuh M., Tilly H., Raemaekers J., van't Veer M.B., Milpied N., Cartron G., Pezzutto A., Spencer A., Reyes F., and Dreyling M. Ann. Oncol. 19 (2008) 247-253
4. Perez-Galan P., Roue G., Villamor N., Campo E., and Colomer D. Blood 109 (2007) 4441-4449
5. Lee K.W., Kim S.G., Kim H.P., Kwon E., You J., Choi H.J., Park J.H., Kang B.C., Im S.A., Kim T.Y., Kim W.H., and Bang Y.J. Cancer Res. 68 (2008) 1916-1926
6. Weigert O., Pastore A., Rieken M., Lang N., Hiddemann W., and Dreyling M. Leukemia 21 (2007) 524-528
7. Weinkauf M., Christopeit M., Hiddemann W., and Dreyling M. Electrophoresis 28 (2007) 4416-4426
8. Weinkauf M., Zimmermann Y., Hartmann E., Rosenwald A., Rieken M., Pastore A., Hutter G., Hiddemann W., and Dreyling M. Electrophoresis 30 (2009) 974-986
9. Rosenwald A., and Staudt L.M. Leuk. Lymphoma 44 Suppl. 3 (2003) S41-S47
10. Paoluzzi L., Gonen M., Bhagat G., Furman R.R., Gardner J.R., Scotto L., Gueorguiev V.D., Heaney M.L., Manova K., and O'Connor O.A. Blood 112 (2008) 2906-2916
11. Heider U., von Metzler I., Kaiser M., Rosche M., Sterz J., Rotzer S., Rademacher J., Jakob C., Fleissner C., Kuckelkorn U., Kloetzel P.M., and Sezer O. Eur. J. Haematol. 80 (2008) 133-142
12. Wang M., Han X.H., Zhang L., Yang J., Qian J.F., Shi Y.K., Kwak L.W., Romaguera J., and Yi Q. Leukemia 22 (2008) 179-185
13. Fernandez V., Hartmann E., Ott G., Campo E., and Rosenwald A. J. Clin. Oncol. 23 (2005) 6364-6369
14. Blank M., and Shiloh Y. Cell Cycle 6 (2007) 686-695
15. McConkey D.J., and Zhu K. Drug Resist. Updat. 11 (2008) 164-179